Process View
Any process that modulates the frequency, rate or extent of increases in the diameter of blood vessels.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of vasodilation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PDZK1 | PDZ domain containing 1 | 0.811 | ||
| SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.565 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.553 | ||
| VAC14 | Vac14 homolog (S. cerevisiae) | 0.519 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.503 | ||
| NOSTRIN | nitric oxide synthase trafficker | 0.491 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.301 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.291 | ||
| DNM1 | dynamin 1 | 0.224 | ||
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.184 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.158 | ||
| PXN | paxillin | 0.126 | ||
| PTEN | phosphatase and tensin homolog | 0.125 | ||
| RLN3 | relaxin 3 | 0.120 | ||
| TBC1D10A | TBC1 domain family, member 10A | 0.118 | ||
| BCR | breakpoint cluster region | 0.104 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.098 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.096 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.095 | ||
| ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | 0.084 | ||
| SRCIN1 | SRC kinase signaling inhibitor 1 | 0.076 | ||
| CLCN3 | chloride channel 3 | 0.072 | ||
| TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.066 | ||
| TNK2 | tyrosine kinase, non-receptor, 2 | 0.065 | ||
| ADRB2 | adrenergic, beta-2-, receptor, surface | 0.064 | Rat | |
| PTPRA | protein tyrosine phosphatase, receptor type, A | 0.062 | ||
| SPRR2A | small proline-rich protein 2A | 0.054 | ||
| CHMP4B | chromatin modifying protein 4B | 0.047 | ||
| GOPC | golgi-associated PDZ and coiled-coil motif containing | 0.045 | ||
| ARRDC3 | arrestin domain containing 3 | 0.042 | ||
| RNF5 | ring finger protein 5 | 0.037 | ||
| PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.036 | ||
| MUC13 | mucin 13, cell surface associated | 0.030 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.030 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.028 | ||
| KRT5 | keratin 5 | 0.028 | ||
| EZR | ezrin | 0.027 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.027 | ||
| ADORA2A | adenosine A2a receptor | 0.025 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.025 | ||
| MTNR1A | melatonin receptor 1A | 0.023 | ||
| RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.023 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.022 | ||
| BDKRB2 | bradykinin receptor B2 | 0.022 | Human | |
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.022 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.021 | ||
| ZNF331 | zinc finger protein 331 | 0.020 | ||
| NOS1AP | nitric oxide synthase 1 (neuronal) adaptor protein | 0.018 | ||
| BDKRB1 | bradykinin receptor B1 | 0.018 | Human | |
| DOCK1 | dedicator of cytokinesis 1 | 0.018 | ||
| CDCP1 | CUB domain containing protein 1 | 0.018 | ||
| P2RY1 | purinergic receptor P2Y, G-protein coupled, 1 | 0.018 | Rat | |
| LGALS4 | lectin, galactoside-binding, soluble, 4 | 0.016 | ||
| EPHA2 | EPH receptor A2 | 0.016 | ||
| FRZB | frizzled-related protein | 0.016 | ||
| LNX1 | ligand of numb-protein X 1 | 0.015 | ||
| PIK3AP1 | phosphoinositide-3-kinase adaptor protein 1 | 0.015 | ||
| USP19 | ubiquitin specific peptidase 19 | 0.015 | ||
| CALCRL | calcitonin receptor-like | 0.014 | ||
| INPPL1 | inositol polyphosphate phosphatase-like 1 | 0.014 | ||
| HDAC6 | histone deacetylase 6 | 0.014 | ||
| MUC1 | mucin 1, cell surface associated | 0.013 | ||
| ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 | 0.013 | ||
| LPXN | leupaxin | 0.013 | ||
| ADCY8 | adenylate cyclase 8 (brain) | 0.013 | ||
| SRY | sex determining region Y | 0.013 | ||
| GNS | glucosamine (N-acetyl)-6-sulfatase | 0.013 | ||
| EPS8L2 | EPS8-like 2 | 0.012 | ||
| KRT8 | keratin 8 | 0.012 | ||
| LY6G6F | lymphocyte antigen 6 complex, locus G6F | 0.012 | ||
| NF2 | neurofibromin 2 (merlin) | 0.012 | ||
| EPCAM | epithelial cell adhesion molecule | 0.012 | ||
| IL1RAPL1 | interleukin 1 receptor accessory protein-like 1 | 0.012 | ||
| TNFSF11 | tumor necrosis factor (ligand) superfamily, member 11 | 0.012 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.012 | ||
| GIT2 | G protein-coupled receptor kinase interacting ArfGAP 2 | 0.012 | ||
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.012 | Rat | |
| PTPN21 | protein tyrosine phosphatase, non-receptor type 21 | 0.012 | ||
| GPR50 | G protein-coupled receptor 50 | 0.011 | ||
| REPS2 | RALBP1 associated Eps domain containing 2 | 0.011 | ||
| PLEKHA6 | pleckstrin homology domain containing, family A member 6 | 0.011 | ||
| RIMS3 | regulating synaptic membrane exocytosis 3 | 0.011 | ||
| LMNA | lamin A/C | 0.011 | ||
| PPP5C | protein phosphatase 5, catalytic subunit | 0.011 | ||
| VAV3 | vav 3 guanine nucleotide exchange factor | 0.011 | ||
| DLGAP2 | discs, large (Drosophila) homolog-associated protein 2 | 0.011 | ||
| CTTN | cortactin | 0.011 | ||
| TNS3 | tensin 3 | 0.011 | ||
| RGS20 | regulator of G-protein signaling 20 | 0.010 | ||
| GRIN2B | glutamate receptor, ionotropic, N-methyl D-aspartate 2B | 0.010 | ||
| SMAD9 | SMAD family member 9 | 0.010 | ||
| PDCD6 | programmed cell death 6 | 0.010 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.010 |